Design and Evaluate 12 Week Group Therapy Intervention for HIV+ Methamphetamine Users and Deliver It Within an HIV/AIDS Primary Care Setting. - 1 - NCT00249678-90024A (Clinical Trial 132974)
Permalink: http://www.ClinicalConnection.com/exp/ExpandedPatientViewStudy132974.aspx
|
** Please review additional "Nearby Studies" on right ----->
|
|
 |
 |
|
| City: |
|
Los Angeles |
|
State:
|
|
CA |
| Zip Code: |
|
90024 |
| Conditions: |
|
Behavior Therapy - Methamphetamine |
| Purpose: |
|
The purpose of this study is...to assess whether placing a substance abuse intervention for
HIV+ methamphetamine users within an HIV medical care setting improves rates of follow-up on
referral to treatment by primary care physicians; reduces drug use and sexual risk behaviors
more than treatment-as-usual; and increases rates of adherence to HIV medication regimens.
|
| Study summary: |
|
|
| Criteria: |
|
Inclusion Criteria:
1. HIV-seropositive, GBM receiving medical treatment for HIV for at least 30 days prior
to signing informed consent at the UCLA CARE clinic, aged 18-65
2. Willing to give informed consent and comply with study procedures;
3. Willing to provide consent to contact treating physicians and pharmacies to assess
adherence to HIV medications;
4. Diagnosed with current methamphetamine abuse as determined by MINI; and
5. Interested in seeking treatment for their methamphetamine abuse and in participating
in this research project.
Exclusion Criteria:
1. Unwilling to give, or withdrawal of, informed consent;
2. Inability to understand nature of study;
3. A psychiatric condition that, in the principal investigator's judgment, warrants
additional intervention to ensure participant safety (e.g., meets DSM-IV-TR criteria
for current bipolar disorder or a psychotic disorder);
4. Current suicidal ideation or suicide attempt within the past 3 months; and
5. Concurrent dependence on opiates, alcohol, or benzodiazepines as determined by MINI.
6. Total lack of any type of healthcare coverage. These potential participants will be
given low-fee treatment referrals. |
|
|
|
| Study is available at: |
|
UCLA Medical Center
Los Angeles, CA 90024
United States |
|
|
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
|
| Trials Alerts: |
|
If you would like to be
notified of new clinical trials as they become available please
register for a free account.
|
|
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
March 15, 2010 |
Modifications to
this listing: |
|
Only selected fields are shown, please use the link
above to view all information about this clinical trial. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Clinical trials are medical research studies designed to test the safety and/or
effectiveness of new drugs, devices, or treatments in humans. These studies are
conducted worldwide for a range of conditions and illnesses. Learn more about
clinical research and participating in a study at
About Clinical Trials.
|
|
|
|
|